Literature DB >> 18955686

A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation.

E Tunnell1, R Wollman, S Mallik, C J Cortes, S J Dearmond, J A Mastrianni.   

Abstract

OBJECTIVE: To define the clinicopathologic, genetic, and pathogenic prion protein (PrP(Sc)) characteristics associated with a novel mutation of the prion protein gene (PRNP).
METHODS: The coding segment of PRNP from the proband and family members was sequenced and the brain of the proband was histologically studied. The Western blot profile of the proteinase K (PK) resistant fraction of PrP(Sc), an approximation of its conformation, or "PrP(Sc)-type," was determined.
RESULTS: We detected a novel mutation at codon 105 of PRNP that results in a serine (S) substitution of proline (P) (P105S), in a young woman who developed progressive aphasia, behavioral changes, dementia, and parkinsonism, lasting 10 years to her death. Histopathologic findings included an intense focus of multicentric PrP-plaques within the hippocampus, punctate plaques scattered throughout the cerebellum, and intense spongiform degeneration focally within the putamen, suggesting a variant of Gerstmann-Sträussler-Scheinker syndrome (GSS). However, PrP(Sc)-typing revealed two PK-resistant PrP(Sc) fragments (approximately 21 and 26 kDa), a pattern not previously detected in GSS.
CONCLUSIONS: This mutation is the third sequence variation at codon 105 of PRNP. The unusual phenotype and PrP(Sc)-type distinguishes this genetic prion disease from typical Gerstmann-Sträussler-Scheinker syndrome and other codon 105 substitutions, suggesting that, in addition to the loss of proline at this position, the PrP(Sc) conformation and phenotype is dependent on the specific amino acid substitution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18955686      PMCID: PMC2676963          DOI: 10.1212/01.wnl.0000330237.94742.fa

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

1.  The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.

Authors:  Eric M Norstrom; James A Mastrianni
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.

Authors:  P Parchi; R Castellani; S Capellari; B Ghetti; K Young; S G Chen; M Farlow; D W Dickson; A A Sima; J Q Trojanowski; R B Petersen; P Gambetti
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

3.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Mutations of the prion protein gene phenotypic spectrum.

Authors:  Gábor G Kovács; Gianriccardo Trabattoni; Johannes A Hainfellner; James W Ironside; Richard S G Knight; Herbert Budka
Journal:  J Neurol       Date:  2002-11       Impact factor: 4.849

5.  A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V.

Authors:  F Tagliavini; P M Lievens; C Tranchant; J M Warter; M Mohr; G Giaccone; F Perini; G Rossi; M Salmona; P Piccardo; B Ghetti; R C Beavis; O Bugiani; B Frangione; F Prelli
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

Review 6.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

7.  Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity.

Authors:  G C Telling; P Parchi; S J DeArmond; P Cortelli; P Montagna; R Gabizon; J Mastrianni; E Lugaresi; P Gambetti; S B Prusiner
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

8.  The sequential development of abnormal prion protein accumulation in mice with Creutzfeldt-Jakob disease.

Authors:  T Muramoto; T Kitamoto; J Tateishi; I Goto
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

9.  Novel prion protein conformation and glycotype in Creutzfeldt-Jakob disease.

Authors:  Gianluigi Zanusso; Alberto Polo; Alessia Farinazzo; Romolo Nonno; Franco Cardone; Michele Di Bari; Sergio Ferrari; Serena Principe; Matteo Gelati; Elisa Fasoli; Michele Fiorini; Frances Prelli; Blas Frangione; Giuseppe Tridente; Marina Bentivoglio; Alessandra Giorgi; Maria Eugenia Schininà; Bruno Maras; Umberto Agrimi; Nicola Rizzuto; Maurizio Pocchiari; Salvatore Monaco
Journal:  Arch Neurol       Date:  2007-04

10.  Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58.

Authors:  F Tagliavini; F Prelli; J Ghiso; O Bugiani; D Serban; S B Prusiner; M R Farlow; B Ghetti; B Frangione
Journal:  EMBO J       Date:  1991-03       Impact factor: 11.598

View more
  9 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  Prion Protein Prolines 102 and 105 and the Surrounding Lysine Cluster Impede Amyloid Formation.

Authors:  Allison Kraus; Kelsie J Anson; Lynne D Raymond; Craig Martens; Bradley R Groveman; David W Dorward; Byron Caughey
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

Review 3.  Hereditary Human Prion Diseases: an Update.

Authors:  Matthias Schmitz; Kathrin Dittmar; Franc Llorens; Ellen Gelpi; Isidre Ferrer; Walter J Schulz-Schaeffer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2016-06-20       Impact factor: 5.590

Review 4.  The consequences of pathogenic mutations to the human prion protein.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  Protein Eng Des Sel       Date:  2009-07-14       Impact factor: 1.650

Review 5.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

Review 6.  Genetic studies in human prion diseases.

Authors:  Byung-Hoon Jeong; Yong-Sun Kim
Journal:  J Korean Med Sci       Date:  2014-04-25       Impact factor: 2.153

7.  Atypical parkinsonism caused by Pro105Leu mutation of prion protein: A broad clinical spectrum.

Authors:  Kagari Koshi Mano; Takashi Matsukawa; Jun Mitsui; Hiroyuki Ishiura; Shin-Ichi Tokushige; Yuji Takahashi; Naoko Saito Sato; Fumiko Kusunoki Nakamoto; Yaeko Ichikawa; Yu Nagashima; Yasuo Terao; Jun Shimizu; Masashi Hamada; Yoshikazu Uesaka; Genko Oyama; Go Ogawa; Jun Yoshimura; Koichiro Doi; Shinichi Morishita; Shoji Tsuji; Jun Goto
Journal:  Neurol Genet       Date:  2016-01-07

8.  Impaired transmissibility of atypical prions from genetic CJDG114V.

Authors:  Ignazio Cali; Fadi Mikhail; Kefeng Qin; Crystal Gregory; Ani Solanki; Manuel Camacho Martinez; Lili Zhao; Brian Appleby; Pierluigi Gambetti; Eric Norstrom; James A Mastrianni
Journal:  Neurol Genet       Date:  2018-08-07

9.  Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene.

Authors:  Giuseppe Di Fede; Marcella Catania; Cristiana Atzori; Fabio Moda; Claudio Pasquali; Antonio Indaco; Marina Grisoli; Marta Zuffi; Maria Cristina Guaita; Roberto Testi; Stefano Taraglio; Maria Sessa; Graziano Gusmaroli; Mariacarmela Spinelli; Giulia Salzano; Giuseppe Legname; Roberto Tarletti; Laura Godi; Maurizio Pocchiari; Fabrizio Tagliavini; Daniele Imperiale; Giorgio Giaccone
Journal:  Acta Neuropathol Commun       Date:  2019-01-03       Impact factor: 7.801

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.